Therapeutic Advances in Hematology (Oct 2021)
Integration of cell therapies and bispecific antibodies into the treatment pathway of relapsed diffuse large B-cell lymphoma
Abstract
No abstracts available.
Therapeutic Advances in Hematology (Oct 2021)